AtriCure shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY26 sales guidance with its midpoint above estimates.
AtriCure, Inc. +2.58%
AtriCure, Inc. ATRC | 29.40 | +2.58% |
AtriCure shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY26 sales guidance with its midpoint above estimates.
